Alvocidib, also known as flavopiridol, is a flavonoid alkaloid that functions as a potent cyclin-dependent kinase 9 (CDK9) inhibitor, currently under clinical investigation for the treatment of acute myeloid… Read more
Alvocidib, also known as flavopiridol, is a flavonoid alkaloid that functions as a potent cyclin-dependent kinase 9 (CDK9) inhibitor, currently under clinical investigation for the treatment of acute myeloid leukemia. This category provides access to high-quality reference standards for Alvocidib and its related compounds, including synthetic derivatives like the fluoro analogue. These materials are essential for researchers and analytical chemists conducting impurity profiling, method validation, and stability testing during pharmaceutical development. By utilizing precise reference standards and stable isotope labelled compounds, laboratories can accurately quantify trace impurities and monitor metabolic pathways, ensuring strict adherence to regulatory quality control standards throughout the development lifecycle. Whether characterizing process-related impurities or validating bioanalytical assays, these compounds serve as critical tools for maintaining the rigorous data integrity required in oncology drug research.